ELAN — ELANCO ANIMAL HEALTH (Healthcare >> Drug Manufacturers - Specialty & Generic)
ELAN FAQ
What is ELAN's P/E ratio?
ELANCO ANIMAL HEALTH (ELAN) currently trades at a P/E ratio of 167.98.
What is ELAN's ROE?
ELANCO ANIMAL HEALTH reports a Return on Equity (ROE) of -3.72%.
What is ELAN's dividend yield?
ELANCO ANIMAL HEALTH offers a dividend yield of 0.00%.
What is ELAN's Deepscope Quality Score?
Deepscope rates ELAN's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy ELAN?
Deepscope's AI Timing Score for ELAN is 94 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does ELAN belong to?
ELANCO ANIMAL HEALTH is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NYSE exchange.
|
USD 24.05
Price
0.12
(0.50%)
Day Change
|
|
|---|
ELAN Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 46) nhưng Thời điểm mua ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
Tỷ lệ P/E tương đối cao
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
Lịch sử ROE tương đối thấp
Tăng trưởng ROE là âm trong năm ngoái.
Tăng trưởng ROA dưới mức tiêu chí của chúng tôi trong năm vừa qua
Biên lợi nhuận ròng tương đối thấp.
Lịch sử Biên lợi nhuận ròng tương đối thấp.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt lắm , và khả năng kiếm lợi nhuận Khá , ...
| Yếu tố Chất lượng |
|
47% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 86 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 24.05 |
| PBV / Sector |
1.76 / 2.57
|
| Earning Per Share | -0.51 |
| PE / Sector |
167.98 / 24.33
|
| PEG or PE/Growth / Sector |
0.43 / 0.12
GOOD
|
| Average 1M Daily Value |
132.41 M
GREAT
|
| Average 1W Daily Value |
116.17 M
GREAT
|
| Yếu tố Kỹ thuật |
|
57% |
| Sức khỏe tài chính |
|
50% |
| Khả năng kiếm lợi nhuận |
|
64% |
| Lợi tức cho nhà đầu tư |
|
4% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-12 09:43:22 |
| Symbol | ELAN |
| Name | ELANCO ANIMAL HEALTH |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NYSE |
| Listed Shares | 499.45 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 11,422.41 / 9,929.32 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 450 Elanco Circle, Indianapolis, IN, United States, 46221
Phone: 877 352 6261
Website: https://www.elanco.com
Employees: 9,400
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio Family, Interceptor Plus, Drontal family, and Drontal Plus; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. It also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, the company offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, it offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and Tru Family trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. The company sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Indianapolis, Indiana.
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
Google